23 Jun, 2020 RNAi Roundtable: ALN-AGT, in Development for the Treatment of Hypertension
On June 23, 2020, we hosted an online RNAi Roundtable to review the progress with ALN-AGT, an RNAi therapeutic in development for the treatment of hypertension.
John Maraganore, Ph.D.
Chief Executive Officer
Akshay Desai, M.D., M.P.H.
Director, Cardiomyopathy and Heart Failure Program, Cardiovascular Division, Brigham and Women’s Hospital;
Associate Professor of Medicine, Harvard Medical School
Jae Kim, M.D.
Vice President, Clinical Development
Senior Director, Program Leader, ALN-AGT